Railways / Cancer Research Technologies / Nexpep/ImmusanT / Genentech / BACE Therapeutics / NHMRC / Becton Dickinson / General Steel Industries Inc / Catalyst Therapeutics / Common sense / Merck / Murigen / Mills AE / Abbott Laboratories / Genera Biosystems / /
Country
Belgium / Japan / United States / Canada / Australia / United Kingdom / /
Currency
USD / /
Event
Business Partnership / Environmental Issue / /
Facility
Eliza Hall Institute / Eliza Hall Institute of Medical Research / /
Holiday
Commonwealth Day / Commonwealth Day of Australia / /
IndustryTerm
public healthcare organisations / provisional patent applications / technology neutral / application law / Cancer Therapeutics / healthcare / healthcare sector / marketable products / patent systems / particular gene patent applications / energy / pharmaceuticals / compulsory licensing applications / patent family applications / technology exemptions / food security / technology transfer / /
MedicalCondition
cancer / inflammation / infectious disease / /
OperatingSystem
Genera / /
Organization
National Institute of Health / Brisbane City Council / Federal Court / Productivity Commission / Intellectual Property and Competition Review Committee / Senate / Federal Government / Eliza Hall Institute / UN Court / Eliza Hall Institute of Medical Research 1G Royal Parade Parkville Victoria / Advisory Council on Intellectual Property / Australian Health Ministers Advisory Council / /
Person
Carmela Monger / Doug Hilton / /
Position
Head Business Development / Director of The Walter / fundamental driver / King / Manager The Walter / Contracts Manager / Professor / Director / state Commissioner / Commissioner / /
Submission 13 - The Walter And Eliza Hall Institute of Medical Research - Compulsory Licensing of Patents public inquiry